In response to the COVID-19 outbreak, the Food and Drug Administration yesterday released updated guidance to provide flexibility and expand the availability of ventilators and other respiratory devices to treat patients during the public health emergency. In addition, FDA released a letter to supplement the updated guidance that provides recommendations directed at providers. Download the AHA Advisory for more information.

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
The Health Resources and Services Administration this week opened the Provider Relief Fund reporting portal through Dec. 2 for health care providers…
Headline
Five medical organizations this week released a toolkit for clinicians in post-acute and long-term care settings about the benefits of the COVID-19 bivalent…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…